Site-directed mutagenesis in Brucella abortus S19 by overlap extension PCR-based procedure

Published: Jan 29, 2018
Brucella abortus S19 Mutation Overlap extension polymerase chain reaction

Introduction of a site-directed mutation can be effective method to evaluate properties of various genes. Brucellosis is one of the most common zoonotic infectious diseases, which causes great economic losses. Thus, determination of pathogenicity factors in the genus Brucella can lead to the control of this health problem. Due to the importance of site-directed mutations in identification of genomic structure, overlap extension polymerase chain reaction (PCR) has been introduced as an improved technique for the removal and replacement of gene targets. In this study, three DNA fragments were amplified and combined using a two-step PCR with specific primers. The resulting fusion PCR product, obtained without any change in the nucleotide sequence, was cloned in a specific position in the pBluescript II SK (-) plasmid using restriction enzymes. Finally, the construct was transferred into cells of Brucella abortus S19 by electroporation and replaced the target gene (wbkA) in the genome of the bacterium. PCR analysis was performed on kanamycin-resistant colonies to provide genetic evidence that the B. abortus wbkA gene was interrupted by the kanamycin cassette. The results of this study show that the optimized modified technique, splicing by overlap extension PCR, is effective in creating mutations in the bacterial genome and can easily be used in Brucella spp.

Article Details
  • Section
  • Research Articles
Download data is not yet available.
Allen CA, Adams LG, Ficht TA (1998) Transposon-Derived Brucella abortus Rough Mutants Are Attenuated and Exhibit Reduced Intracellular Survival. Infection and Immunity 66(9):1008-1016.
Bikard D, Jiang W, Samai P, Hochschild A, Zhang F, Marraffini LA (2013) Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Research 41(15):7429-7437.
Bryksin AV, Matsumura I (2010) Overlap extension PCR cloning: a simple and reliable way to create recombinant plasmids. BioTechniques 48:463-465.
Chou IC, Olszewski NE, Cheng CP (2004) Generation of Random, In-Frame Mutations by TN1000-Mediated Mutagenesis. Journal of Genetics and Molecular Biology 2:137-142.
Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proceeding of the National Academy of Sciences of the United States of America 97(12):6640-6645.
Denamur E, Matic I (2006) Evolution of mutation rates in bacteria. Molecular Microbiology 60(4):820-827.
Higuchi R, Krummel B, Saiki RK (1988) A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Research 16(15):7351-7367.
Horton RM (1995) PCR-mediated recombination and mutagenesis. SOEing together tailor-made genes. Molecular Biotechnology 3(2):93-99.
Horton RM, Cai ZL, Ho SN, Pease LR (1990) Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. Biotechniques 8(5):528-35.
Kahl-McDonagh MM, Ficht TA (2006) Evaluation of Protection Afforded by Brucella abortus and Brucella melitensis Unmarked Deletion Mutants Exhibiting Different Rates of Clearance in BALB/c Mice. Infection and Immunity 74(7):4048-4057.
Luo WG, Liu HZ, Lin WH, Kabir MH, Su Y (2013) Simultaneous splicing of multiple DNA fragments in one PCR reaction. Biological Procedures Online 15:9.
Miyoshi A, Rosinha GM, Camargo IL, Trant CM, Cardoso FC, Azevedo V,Oliveira SC (2007) The role of the vacB gene in the pathogenesis of Brucella abortus. Microbes and Infection 9(3):375-381.
Monreal D, Grillo MJ, Gonza´lez D (2003) Characterization of Brucella abortus O-Polysaccharide and Core Lipopolysaccharide Mutants and Demonstration that a Complete Core Is Required for Rough Vaccines To Be Efficient against Brucella abortus and Brucella ovis in the Mouse Model. Infection and Immunity 71(6):3261-3271.
Nikolich MP, Warren RL, Lindler LE, Izadjoo MJ, Hoover DL (2010) Attenuation of defined Brucella melitensis wboA mutants. Vaccine 28S: F12-F16.
Poester FP, Samartino LE, Santos RL (2013) Pathogenesis and pathobiology of brucellosis in livestock. Rev Sci Tech Off Int Epiz 32(1):105-115.
Soler-Lloréns P, Gil-Ramírez Y, Zabalza-Baranguá A, Iriarte M, CondeÁlvarez R, Zúñiga-Ripa A, San Román B (2014) Mutants in the lipopolysaccharide of Brucella ovis are attenuated and protect against B. ovis infection in mice. Veterinary Research 45-72.
Ugalde JE, Comerci DJ, Leguizamón MS, Ugalde RA (2003) Evaluation of Brucella abortus Phosphoglucomutase (pgm) Mutant as a New Live Rough-Phenotype Vaccine. Infection and Immunity71(11):6264-6269.
Xavier MN, Paixão TA, Hartigh AB, Tsolis RM, Santos RL (2010) Pathogenesis of Brucella spp.. Veterinary Science Journal 4:109-118
Most read articles by the same author(s)